Advertisement

Journal of General Internal Medicine

, Volume 33, Issue 8, pp 1229–1231 | Cite as

Gout and Hypothyroidism in the Elderly: an Observational Cohort Study Using U.S. Medicare Claims Data

  • Jasvinder A. SinghEmail author
  • John D. Cleveland
Concise Research Reports
  • 101 Downloads

INTRODUCTION

Given the known association of hypothyroidism and hyperuricemia, a link between gout and hypothyroidism has long been suspected, but rarely investigated. Two small studies in hospitalized patients1 or at a single medical center2 suggested a higher risk of hypothyroidism in people with gout. These studies included small samples, controlled for only select demographic variables and none focused on the elderly, the population at the highest risk of hypothyroidism. Well-designed studies that can control for potential confounders can provide a robust estimate of this potential association are needed. Our objective was to examine whether gout, the most common inflammatory arthritis in adults, was associated with an increase in the risk of incident hypothyroidism in adults 65 years or older.

METHODS

We used the 5% random Medicare claims data to conduct this cohort study. Patients were considered eligible for this analysis, if they received Medicare fee-for-service (parts A or B)...

Notes

Acknowledgements

We thank Dr. Jeffrey Curtis of the UAB Division of Rheumatology, who permitted us to re-use the 5% Medicare data. We thank patients at the University of Alabama gout clinic for asking us questions about comorbidities of gout and whether gout may be related to their other conditions, which prompted us to ask this question.

Funding/Support

This material is the result of work supported by research funds from the Division of Rheumatology at the University of Alabama at Birmingham and the resources and use of facilities at the Birmingham VA Medical Center, Birmingham, Alabama, USA.

Role of the Funder/Supporter

The funding body did not play any role in the design, collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.

Author Contributions

Mr. Cleveland had full access to all of the data in the study and takes the responsibility for the integrity of the data and accuracy of the data analysis. He was supervised by Dr. Singh, who reviewed all results.

Study Concept and Design: Singh.

Data acquisition, analysis and interpretation of results: Singh, Cleveland

Drafting of the manuscript: Singh

Critical revision of the manuscript for important intellectual content: Singh, Cleveland

Statistical analysis: Cleveland

Obtained Funding: Singh

Administrative, technical or material support: Singh

Study Supervision: Singh

Compliance with Ethical Standards

Conflict of Interest

JAS has received research grants from Takeda and Savient and consultant fees from Savient, Takeda, Regeneron, Merz, Iroko, Bioiberica, Crealta/Horizon and Allergan pharmaceuticals, WebMD, UBM LLC and the American College of Rheumatology. JAS serves as the principal investigator for an investigator-initiated study funded by Horizon pharmaceuticals through a grant to DINORA, Inc., a 501 (c)(3) entity. JAS is a member of the executive of OMERACT, an organization that develops outcome measures in rheumatology and receives arms-length funding from 36 companies; a member of the American College of Rheumatology’s (ACR) Annual Meeting Planning Committee (AMPC); Chair of the ACR Meet-the-Professor, Workshop and Study Group Subcommittee; and a member of the Veterans Affairs Rheumatology Field Advisory Committee. JAS is the editor and Director of the UAB Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis. DC has no conflicts to declare. There are no non-financial competing interests for any of the authors.

Ethics/IRB Approval and Consent to Participate

The University of Alabama at Birmingham’s Institutional Review Board approved this study and waived the need for informed consent for this database study. All investigations were conducted in conformity with ethical principles of research.

REFERENCES

  1. 1.
    Durward WF. Letter: Gout and hypothyroidism in males. Arthritis Rheum 1976;19:123.Google Scholar
  2. 2.
    Erickson AR, Enzenauer RJ, Nordstrom DM, Merenich JA. The prevalence of hypothyroidism in gout. Am J Med 1994;97:231–4.CrossRefGoogle Scholar
  3. 3.
    Singh JA, Hodges JS, Toscano JP, Asch SM. Quality of care for gout in the US needs improvement. Arthritis Rheum 2007;57:822–9.CrossRefGoogle Scholar
  4. 4.
    Marrie RA, Yu BN, Leung S, Elliott L, Warren S, Wolfson C, et al. The incidence and prevalence of thyroid disease do not differ in the multiple sclerosis and general populations: a validation study using administrative data. Neuroepidemiology 2012;39:135–42.CrossRefGoogle Scholar
  5. 5.
    Tonelli M, Wiebe N, Fortin M, Guthrie B, Hemmelgarn BR, James MT, et al. Methods for identifying 30 chronic conditions: application to administrative data. BMC Med Inform Decis Mak 2015;15:31.CrossRefGoogle Scholar
  6. 6.
    Kvetny J, Heldgaard PE, Bladbjerg EM, Gram J. Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol (Oxf) 2004;61:232–8.CrossRefGoogle Scholar

Copyright information

© Society of General Internal Medicine (This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply) 2018

Authors and Affiliations

  1. 1.Medicine Service, VA Medical CenterBirminghamUSA
  2. 2.Department of Medicine at School of Medicine, Division of Epidemiology at School of Public Health University of Alabama at BirminghamBirminghamUSA

Personalised recommendations